Pyrbuterol: a new bronchodilator. Phase I-single dose study.
D000328:Adult; D000368:Aged; D000403:Airway Resistance; D001249:Asthma / Q000188:drug therapy; D001794:Blood Pressure; D001986:Bronchial Spasm / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002082:Butylamines / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D010993:Plethysmography, Whole Body; D011674:Pulse; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D001993:Bronchodilator Agents; D002082:Butylamines; D004983:Ethanolamines; D010919:Placebos; D011725:Pyridines; C009118:pirbuterol